Bombardier (BBD.A) Competitors C$163.97 -3.49 (-2.08%) As of 08/8/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock BBD.A vs. ARZ, AIR, SPR, MDA, HRX, MAL, FTG, VOL, AVP, and FLYShould you be buying Bombardier stock or one of its competitors? The main competitors of Bombardier include Aralez Pharmaceuticals (ARZ), Clean Air Metals (AIR), Spirit AeroSystems (SPR), MDA Space (MDA), Héroux-Devtek (HRX), Magellan Aerospace (MAL), Firan Technology Group (FTG), Volatus Aerospace (VOL), Avcorp Industries (AVP), and FLYHT Aerospace Solutions (FLY). Bombardier vs. Its Competitors Aralez Pharmaceuticals Clean Air Metals Spirit AeroSystems MDA Space Héroux-Devtek Magellan Aerospace Firan Technology Group Volatus Aerospace Avcorp Industries FLYHT Aerospace Solutions Bombardier (TSE:BBD.A) and Aralez Pharmaceuticals (TSE:ARZ) are both aircraft companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings. Do institutionals & insiders hold more shares of BBD.A or ARZ? 2.0% of Bombardier shares are owned by institutional investors. 84.8% of Bombardier shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the media refer more to BBD.A or ARZ? In the previous week, Bombardier had 2 more articles in the media than Aralez Pharmaceuticals. MarketBeat recorded 2 mentions for Bombardier and 0 mentions for Aralez Pharmaceuticals. Bombardier's average media sentiment score of 0.38 beat Aralez Pharmaceuticals' score of 0.00 indicating that Bombardier is being referred to more favorably in the media. Company Overall Sentiment Bombardier Neutral Aralez Pharmaceuticals Neutral Which has better earnings & valuation, BBD.A or ARZ? Bombardier has higher revenue and earnings than Aralez Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBombardierC$8.40B0.24C$276MC$3.8642.48Aralez PharmaceuticalsN/AN/AN/AN/AN/A Is BBD.A or ARZ more profitable? Bombardier has a net margin of 3.65% compared to Aralez Pharmaceuticals' net margin of 0.00%. Company Net Margins Return on Equity Return on Assets Bombardier3.65% N/A 4.11% Aralez Pharmaceuticals N/A N/A N/A SummaryBombardier beats Aralez Pharmaceuticals on 7 of the 7 factors compared between the two stocks. Get Bombardier News Delivered to You Automatically Sign up to receive the latest news and ratings for BBD.A and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BBD.A and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BBD.A vs. The Competition Export to ExcelMetricBombardierAerospace & Defense IndustryIndustrials SectorTSE ExchangeMarket CapC$2.03BC$13.26BC$7.61BC$6.34BDividend Yield3.32%2.67%4.57%6.72%P/E Ratio42.4859.8724.9762.43Price / Sales0.2497.3099.471,654.03Price / Cash3.7121.4027.9883.29Price / Book-6.514.524.304.89Net IncomeC$276MC$223.64MC$795.91MC$301.20M7 Day Performance0.21%1.56%1.09%1.82%1 Month Performance5.35%1.49%1.44%1.87%1 Year Performance92.68%129.65%33.85%30.40% Bombardier Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BBD.ABombardierN/AC$163.97-2.1%N/A+98.6%C$2.03BC$8.40B42.4817,100News CoverageARZAralez PharmaceuticalsN/AN/AN/AN/AC$28.89MN/A0.004,500Gap UpHigh Trading VolumeAIRClean Air MetalsN/AC$0.05flatN/A+57.1%C$10.45MN/A-2.254,500Positive NewsHigh Trading VolumeSPRSpirit AeroSystemsN/AN/AN/AN/A$0.00N/A0.0018,200News CoverageHigh Trading VolumeMDAMDA Space1.837 of 5 starsC$39.74-0.3%C$35.78-10.0%+210.2%C$4.85BC$952.93M70.633,000Trending NewsAnalyst ForecastAnalyst RevisionHRXHéroux-DevtekN/AN/AN/AN/AC$1.09BC$695.14M20.962,100MALMagellan Aerospace1.6723 of 5 starsC$16.79+0.7%C$20.00+19.1%+96.2%C$928.90MC$895.80M48.043,850News CoveragePositive NewsFTGFiran Technology Group1.2396 of 5 starsC$11.79+2.1%C$13.00+10.3%+93.6%C$297.14MC$166.24M27.65450News CoverageNegative NewsVOLVolatus AerospaceN/AC$0.26-1.9%N/A+13.3%C$114.38MC$116.08M-3.59N/ANews CoverageAVPAvcorp IndustriesN/AN/AN/AN/AC$38.95MC$108.27M-1.9123,000Gap DownHigh Trading VolumeFLYFLYHT Aerospace SolutionsN/AC$0.34-2.9%N/A+19.3%C$13.26MC$17.75M-2.09N/AGap Down Related Companies and Tools Related Companies ARZ Competitors AIR Competitors SPR Competitors MDA Competitors HRX Competitors MAL Competitors FTG Competitors VOL Competitors AVP Competitors FLY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:BBD.A) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bombardier Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bombardier With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBD.A Stock Alerts